XML 42 R30.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value of Financial Instruments and Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Estimates of Financial Instruments

Fair value estimates of the Company’s financial instruments as of September 30, 2025 and December 31, 2024, including methods and assumptions utilized, are set forth below:

   

   amount   Level 1   Level 2   Level 3   Total 
   As of September 30, 2025 
   Carrying                 
   amount   Level 1   Level 2   Level 3   Total 
Financial assets:                         
Cash and cash equivalents  $23,947   $23,947   $-   $-   $23,947 
Interest-bearing deposits at other banks   3,218    -    3,218    -    3,218 
Investment securities available-for-sale   350,028    50,833    299,195    -    350,028 
Investment securities held-to-maturity   3,760    -    3,468    -    3,468 
Bank stocks, at cost   8,021     n/a      n/a      n/a      n/a  
Loans, net   1,104,991    -    -    1,106,896    1,106,896 
Loans held for sale   3,578    -    3,578    -    3,578 
Mortgage servicing rights   3,120    -    8,718    -    8,718 
Accrued interest receivable   7,192    225    1,799    5,168    7,192 
Derivative financial instruments   229    -    229    -    229 
    Derivative assets    Derivative assets    Derivative assets    Derivative assets    Derivative assets 
                          
Financial liabilities:                         
Non-maturity deposits  $(1,091,663)  $(1,091,663)  $-   $-   $(1,091,663)
Certificates of deposit   (233,837)   -    (233,262)   -    (233,262)
FHLB and other borrowings   (90,483)   -    (90,453)   -    (90,453)
Subordinated debentures   (21,651)   -    (18,760)   -    (18,760)
Repurchase agreements   (1,420)   -    (1,420)   -    (1,420)
Accrued interest payable   (1,742)   -    (1,742)   -    (1,742)

 

   amount   Level 1   Level 2   Level 3   Total 
   As of December 31, 2024 
   Carrying                 
   amount   Level 1   Level 2   Level 3   Total 
Financial assets:                         
Cash and cash equivalents  $20,275   $20,275   $-   $-   $20,275 
Interest-bearing deposits at other banks   4,110    -    4,110    -    4,110 
Investment securities available-for-sale   372,512    64,458    308,054    -    372,512 
Investment securities held-to-maturity   3,672    -    3,290    -    3,290 
Bank stocks, at cost   6,618    n/a     n/a     n/a      n/a  
Loans, net   1,039,221    -    -    1,027,865    1,027,865 
Loans held for sale   3,420    -    3,420    -    3,420 
Mortgage servicing rights   3,061    -    9,615    -    9,615 
Accrued interest receivable   7,132    219    2,001    4,912    7,132 
Derivative financial instruments   200    -    200    -    200 
                          
Financial liabilities:                         
Non-maturity deposits  $(1,134,072)  $(1,134,072)  $-   $-   $(1,134,072)
Certificates of deposit   (194,694)   -    (193,901)   -    (193,901)
FHLB and other borrowings   (53,046)   -    (48,846)   -    (48,846)
Subordinated debentures   (21,651)   -    (18,556)   -    (18,556)
Repurchase agreements   (13,808)   -    (13,808)   -    (13,808)
Accrued interest payable   (1,833)   -    (1,833)   -    (1,833)
Schedule of Fair Value Instruments Measured on Recurring Basis

The following tables represent the Company’s financial instruments that are measured at fair value on a recurring basis as of September 30, 2025 and December 31, 2024, allocated to the appropriate fair value hierarchy:

   

   Total   Level 1   Level 2   Level 3 
(Dollars in thousands)      As of September 30, 2025 
       Fair value hierarchy 
   Total   Level 1   Level 2   Level 3 
Assets:                
Available-for-sale investment securities:                    
U. S. treasury securities  $50,833   $50,833   $-   $- 
Municipal obligations, tax exempt   97,383    -    97,383    - 
Municipal obligations, taxable   82,236    -    82,236    - 
Agency mortgage-backed securities   119,576    -    119,576    - 
Loans held for sale   3,578    -    3,578    - 
Derivative financial instruments   229    -    229    - 

 

   Total   Level 1   Level 2   Level 3 
       As of December 31, 2024 
       Fair value hierarchy 
   Total   Level 1   Level 2   Level 3 
Assets:                
Available-for-sale investment securities:                    
U. S. treasury securities  $64,458   $64,458   $-   $- 
Municipal obligations, tax exempt   107,128    -    107,128    - 
Municipal obligations, taxable   71,715    -    71,715    - 
Agency mortgage-backed securities   129,211    -    129,211    - 
Loans held for sale   3,420    -    3,420    - 
Derivative financial instruments   200    -    200    - 
Schedule of Fair Value Contractual Balance and Gain Loss on Loans Held for Sale

The aggregate fair value, contractual balance (including accrued interest), and gains on loans held for sale as of September 30, 2025 and December 31, 2024 were as follows:

   

   As of   As of 
   September 30,   December 31, 
(Dollars in thousands)  2025   2024 
Aggregate fair value  $3,578   $3,420 
Contractual balance   3,529    3,376 
Gain  $49   $44 
Schedule of Gains from Changes in Fair Value of Derivative Financial Instruments

   

(Dollars in thousands)            
   Three months ended   Nine months ended 
   September 30,   September 30, 
(Dollars in thousands)  2025   2024   2025   2024 
Total change in fair value  $10   $(42)  $29   $173 
Schedule of Fair Value Measurements on Nonrecurring, Valuation Techniques

The following table presents quantitative information about Level 3 fair value measurements measured at fair value on a nonrecurring basis as of September 30, 2025 and December 31, 2024:

   

(Dollars in thousands)              
   Fair value   Valuation technique  Unobservable inputs  Range 
As of September 30, 2025                
Individual evaluated loans:                
One-to-four family residential real estate  $116   Sales comparison  Adjustment to appraised value   20%
Commercial   2,142   Sales comparison  Adjustment to comparable value   0%-35 %
                 
As of December 31, 2024                
Individual evaluated loans:                
Commercial  $1,768   Sales comparison  Adjustment to comparable value   0%-50%